Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Li'er Mian Capsules (利尔眠胶囊) is a Traditional Chinese Medicine (TCM) product developed and manufactured by Chengdu Jiuzhitang Jinding Pharmaceutical. It is approved in China for the treatment of sleep disorders, particularly insomnia characterized by difficulty falling asleep, frequent dreaming, and restlessness. The formulation is designed to nourish the heart and calm the spirit (Yang Xin An Shen), a traditional therapeutic approach for addressing neurasthenia and anxiety-related sleep disturbances. It typically contains a blend of herbal ingredients such as Ganoderma and Semen Ziziphi Spinosae, which are traditionally used to regulate the central nervous system and improve sleep quality. As an approved pharmaceutical product in the Chinese market, it is utilized to alleviate symptoms of restlessness and improve overall sleep architecture.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Li'er Mian Capsules.